VALSOLE Newsroom

New Trial Protocol Tests Cushioned Insoles Against a Sham, Not a Product Ranking

A new study protocol is useful for understanding what researchers plan to test, but it is not evidence that the planned intervention has worked.
Why it matters

Orthotics, insoles, and support-feel comparisons

Shifts in the insole and orthotic market often change what shoppers expect from arch feel, stability, and long-wear comfort.

What to compare next

Use this report to narrow which support profile, arch guidance page, or stronger insole path to review next.

Move from this report into the most relevant support path, product lane, or guidance page without leaving the newsroom flow.

Quick Answer: A Trial Protocol Is Not a Trial Result

A 2026 protocol describes the SOLE randomized trial, which plans to compare cushioned insoles with visually similar sham insoles in adults with first metatarsophalangeal joint osteoarthritis. The paper explains a research design; it does not report clinical outcomes or evaluate VALSOLE products.

What Happened

The planned study will randomize participants to cushioned or sham insoles for 12 weeks and assess participant-reported outcomes. Publishing the protocol makes the intended comparison and outcome plan visible before results are known.

Why It Matters Now

Insole headlines often blur the line between a study launch and a completed result. A sham-controlled design can be useful because it tests an intervention against a comparison condition, but the design alone cannot establish benefit.

Consumer Decision Context

  1. Read protocol, pilot and completed-trial headlines as different evidence stages.
  2. Do not infer that a clinical research insole matches a retail product.
  3. For a diagnosed condition, use individualized clinical advice rather than a general shopping article.

VALSOLE Support Path

The Insoles Complete Guide explains general selection factors such as shoe fit and daily use. Readers can then browse the Insoles collection or use Quick Match.

What This Means for Readers

The useful current news is methodological: the study has drawn a clearer comparison plan. Results, limitations and applicability need to wait for the completed trial.

Sources